Low iron diet reduces development of atherosclerosis in apoE-deficient mice

被引：0
|
作者：
Chau, LY [1 ]
Lee, TS [1 ]
Pan, CC [1 ]
机构：
[1] ACAD SINICA,INST BIOMED SCI,CARDIOVASC DIS RES,TAIPEI,TAIWAN
来源：
ATHEROSCLEROSIS | 1997年 / 134卷 / 1-2期
关键词：
D O I：
10.1016/S0021-9150(97)88279-2
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：37 / 37
页数：1
相关论文
共 50 条
  • [21] FENRETINIDE DIFFERENTLY AFFECTS ATHEROSCLEROSIS DEVELOPMENT AND METABOLIC PARAMETERS IN APOE-DEFICIENT MICE
    Parolini, Cinzia
    Manzini, Stefano
    Busnelli, Marco
    Ferrari, Benedetta
    Colombo, Alice
    Scanziani, Eugenio
    Chiesa, Giulia
    ATHEROSCLEROSIS SUPPLEMENTS, 2018, 32 : 161 - 161
  • [22] Macrophage retinoblastoma deficiency leads to enhanced atherosclerosis development in ApoE-deficient mice
    Boesten, Lianne S. M.
    Zadelaar, A. Susanne M.
    van Nieuwkoop, Anita
    hu, Lii Hu
    Jonkers, Jos
    de Water, Bob van
    Gijbels, Marion J. J.
    van der Made, Ingeborg
    de Winther, Menno P. J.
    Havekes, Louis M.
    van Vlijmen, Bart J. M.
    FASEB JOURNAL, 2006, 20 (07): : 953 - +
  • [23] Roles of thromboxane A2 and prostacyclin in the development of atherosclerosis in apoE-deficient mice
    Kobayashi, T
    Tahara, Y
    Matsumoto, M
    Iguchi, M
    Sano, H
    Murayama, T
    Arai, H
    Oida, H
    Yurugi-Kobayashi, T
    Yamashita, JK
    Katagiri, H
    Majima, M
    Yokode, M
    Kita, T
    Narumiya, S
    JOURNAL OF CLINICAL INVESTIGATION, 2004, 114 (06): : 784 - 794
  • [24] Roles of thromboxane A2 and prostacyclin in the development of atherosclerosis in apoE-deficient mice
    Kobayashi, T.
    Oida, H.
    Yurugi-Kobayashi, T.
    Katagiri, H.
    Majima, M.
    Yokode, M.
    Kita, T.
    Narumiya, S.
    ATHEROSCLEROSIS SUPPLEMENTS, 2006, 7 (03) : 195 - 195
  • [25] Corylin Inhibits Vascular Cell Inflammation, Proliferation and Migration and Reduces Atherosclerosis in ApoE-Deficient Mice
    Chen, Chin-Chuan
    Li, Hung-Yuan
    Leu, Yann-Lii
    Chen, Yu-Ju
    Wang, Chia-Jen
    Wang, Shu-Huei
    ANTIOXIDANTS, 2020, 9 (04)
  • [26] A novel endothelial nitric oxide synthase expression enhancer reduces atherosclerosis in apoE-deficient mice
    Wohlfart, P
    Tiemann, M
    Strobel, H
    Suzuki, T
    Dharanipragada, R
    Li, H
    Foerstermann, U
    Ruetten, H
    CIRCULATION, 2002, 106 (19) : 213 - 213
  • [27] Development of atherosclerotic calcification in apoE-deficient mice
    Shioi, A
    Kizu, A
    Jono, S
    Koyama, H
    Okuno, Y
    Nishizawa, Y
    ATHEROSCLEROSIS SUPPLEMENTS, 2003, 4 (02) : 151 - 152
  • [28] Low levels of extrahepatic nonmacrophage ApoE inhibit atherosclerosis without correcting hypercholesterolemia in ApoE-deficient mice
    Thorngate, FE
    Rudel, LL
    Walzem, RL
    Williams, DL
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2000, 20 (08) : 1939 - 1945
  • [29] Valproate Attenuates Accelerated Atherosclerosis in Hyperglycemic ApoE-Deficient Mice
    Bowes, Anna J.
    Khan, Mohammad I.
    Shi, Yuanyuan
    Robertson, Lindsie
    Werstuck, Geoff H.
    AMERICAN JOURNAL OF PATHOLOGY, 2009, 174 (01): : 330 - 342
  • [30] Protective effects of ramalin against atherosclerosis in ApoE-deficient mice
    Park, Hye-Jin
    Byeon, Hye-Eun
    Koo, Hyun-Jung
    Yim, Joung Han
    Lee, Hong Kum
    Pyo, Suhkneung
    FASEB JOURNAL, 2011, 25
12345